
Objective: Chronic hepatitis B is a growing worldwide public health issue. Its prevalence and the mode of transmission of the virus varies greatly between parts of the world. Hepatitis B is a serious infection of the liver caused by the hepatitis B virus (HBV) and can lead to premature death from cirrhosis (scarring of the liver), liver failure, or liver cancer. This study was designed to assess the Chronic HBV Infection. Methods: RT-PCR, HBeAg & Anti-HBe are performed to know the viral load, Infectivity level & effect of Antiviral Treatment from the Hepatitis B positive Patients. Results: Chronic HBV infection is dangerous because there are often no symptoms. Conclusions: Chronic HBV infection is the leading cause of hepatocellular carcinoma (HCC), the most common type of primary liver cancer. People chronically infected with HBV are 100 times more likely to develop liver cancer than those who are not infected